- Discussing Nestles’ priorities across the microbiome industry for meeting un-met patient needs and partnering with innovative biotech companies.
- Reviewing the post-market landscape of VOWST, providing lessons learnt from commercialization of an FDA approved therapeutic.
Speaker(s):
Speaker
Moreno Perugini
President Pharma
Nestle Health Sciences